Children oncology group (COG) risk stratification system determines the protocol of management used for neuroblastoma patients. COG risk stratification system divides the patients into 03 groups: low risk, intermediate risk and high risk patients. Low risk neuroblastoma patients are usually managed by either observation or surgical resection of the tumor. Intermediate risk patients are managed by neoadjuvant therapy in advance of a definitive surgical resection. High risk neuroblastoma patients are usually managed by a combination of surgery, chemotherapy, radiation therapy, hematopoietic stem cell transplantation, immunotherapy and isotretrinoin.
Neuroblastoma medical therapy
Germinoma medical therapy
Wilms' tumor medical therapy
Neuroblastoma surgery
Brain Stem Gliomas medical therapy
Glioma medical therapy
Sheehan's syndrome medical therapy
Wilms' tumor surgery